Screening for methicillin-resistant Staphylococcus aureus (MRSA) carriage in patients at risk was evaluated as part of a control program in a 26-bed medical intensive care unit (ICU) of a university hospital with a high level of endemic MRSA. Control measures included isolation and barrier precautions, skin decolonization with chlorhexidine of patients from whom MRSA was recovered, and mupirocin treatment of nasal carriers of MRSA. Of 3,686 patients admitted during a 4-year period, 44% were screened, which occurred during admission for 38%; MRSA was recovered from 293 patients (8%). There were 150 imported cases and 143 ICU-acquired cases, of which 51% and 45%, respectively, were first identified through screening. Nasal swab cultures identified 84% of MRSA carriers. The incidence of all ICU-acquired cases and of acquired colonization or infection decreased from 5.8% and 5.6% to 2.6% and 1.4% (P Å .002 and P õ .001), respectively, whereas that of imported cases remained unchanged (range, 3.8% to 4.3%; P Å .8). Selective screening for nasal carriage during admission to high-risk areas may contribute to identification of a substantial proportion of cases of MRSA and to early implementation of effective control measures.
The spread of strains of methicillin-resistant Staphylococcus proportion of patients may present with MRSA colonization at the time of admission. Such patients may not be readily identiaureus (MRSA) has become a major problem in many hospitals worldwide, and MRSA strains now commonly account for fied, or the information may be lacking or not mentioned during transfers or readmissions; therefore, early implementation of 20% -40% of all S. aureus isolates in hospitals where these strains are endemic [1, 2] . In such settings, the circulation isolation precautions to avoid cross-transmission of MRSA to other hospitalized patients [14] may be hampered if such inof resistant strains between health care institutions and the community is challenging control programs [3 -5] . As a consefected or colonized patients, and possibly carriers, are not identified in a timely fashion. Screening of MRSA carriers may be quence of this increasing rate of MRSA carriage in patients discharged from hospitals, MRSA carriage or infection is now useful for this purpose; in addition, early detection of carriers may allow attempts at decontamination [15, 16] and reduce being commonly described in patients readmitted or even newly admitted from the community to hospitals [4, 6, 7] . the risk of cross-transmission or possibly prevent secondary infection in carriers. Identification of the whole hospital reservoir of resistant strains is one major component of a control program for MRSA However, both the strategy for and the usefulness of screening for MRSA carriage remain debated [2, 8, 9, 17] . In large [8 -10] . Although contamination of the hospital environment may play an important role in specific circumstances, patients hospitals, not all patients can be screened for MRSA carriage upon admission, and patients must be selected to undergo colonized or infected with MRSA represent the major hospital reservoir. Studies during epidemics have shown that routine screening for MRSA carriage; however, the population who would be targeted for screening has not been adequately desurveillance sampling for identification of MRSA at usual clinical sites may be appropriate to identify new cases [11, 12] .
fined. To help refine strategies for screening and to evaluate its contribution to the detection of cases of MRSA and its However, in areas where MRSA is endemic, transfer of patients between units or hospitals and readmissions are major contribupotential impact on control measures for prevention of hospitalacquired MRSA colonization and infection, we analyzed the tors to the spread of MRSA [11, 13] . In this setting, a substantial results of a 4-year control program that included screening for MRSA carriage in a high-risk area of a university hospital with a high level of endemic MRSA.
There is an average of 55,000 admissions per year. The largest high-risk areas, those with a history of major surgery within the past 5 years, or those with a known history of MRSA ICU of the hospital, a medical ICU (MICU), comprises 26 beds in two contiguous wards: an acute-care area that has four colonization or infection. In the early phase of the study period (1993 -1994) , samples from several sites (nasal mucosa, perisubunits with two beds each and an isolation unit with five beds in separate rooms and an intermediate-care unit that has neum, and axilla) were obtained during admission and then once weekly from patients with prolonged ICU stays. During five rooms with two beds and three rooms with one bed. This unit admits Ç900 patients per year, and the average number the second part of the study (mid-1995 and 1996) , only nasal swab specimens were obtained at the time of admission and of patient-days per year is 7,000. About one-half the patients are admitted from the emergency department, and the reonce weekly. Samples were obtained with use of premoistened cotton-tip swabs. maining patients are admitted from other medical or surgical wards of the hospital, including other ICUs and other acuteSwabs were streaked on selective media for detection of MRSA. During the first part of the study, Chapman agar was care or long-term-care facilities.
MRSA has been endemic in this hospital since as early as used; during the second part of the study, Mueller-Hinton agar supplemented with tobramycin (10 mg/L) was used, since the 1970s. During the years 1970 -1980, MRSA represented between 15% and 30% of all S. aureus isolates; in the early ú95% of MRSA strains at our hospital expressed tobramycin resistance and since MRSA strains could be detected within 1990s, the proportion of MRSA isolates increased again to a peak of nearly 40%, with Ç500 new cases of MRSA per year õ48 hours with use of this medium. Colonies suspected during morphological examination of S. aureus were further identified [18] . Because of this alarming increase, the hospital's Infection Control Committee launched a control program in 1992 -1993 by using the thermostable DNase reaction, and their antibiotic susceptibility pattern was determined by using the disk diffuwhereby patients from whom MRSA was recovered were to be put in individual rooms and contact-isolation precautions sion technique with 5-mg oxacillin disks incubated for 24 hours at 30ЊC as recommended by the Antibiogram Committee of were to be followed. A screening program was implemented in some of the high-risk areas with a known high prevalence the French Society for Microbiology [19] . S. aureus strains for which oxacillin inhibition zones of õ20 mm (corresponding of MRSA. We describe the results of the first 4 years of this program in the MICU, one of the first high-risk units to be to an MIC of ú2 mg/L) were found were identified as MRSA.
Definitions. For the purpose of this analysis, definitions included in the early phase of the control program for MRSA.
Following implementation of the control program, all MICU were as follows: case, a patient from whom MRSA was recovered from any site; carrier, patient for whom MRSA was recovpatients from whom MRSA was recovered were put in isolation in a private room or two-bed cubicle. When several patients ered from screening samples in the absence of or before isolation of MRSA from any clinical diagnostic sample; infection, from whom MRSA was recovered were simultaneously present in the MICU, they were grouped whenever possible in one or recovery of MRSA from clinical diagnostic samples submitted to the clinical microbiology laboratory at any time during the two cubicles, and the same personnel cared for them. Isolation and barrier precautions were enforced, and personnel were to ICU stay; and colonization, recovery of MRSA from a clinical diagnostic sample in the absence of systemic signs of sepsis or wear gloves and gowns for all contacts with patients or their environment and a mask when caring for intubated patients local overt infection. Cases were further classified as imported (when the first MRSA isolate from whichever source in a given with respiratory tract colonization or infection with MRSA or extensive skin or wound colonization with MRSA. Hand washpatient was recovered £72 hours after admission to the MICU and/or the patient was known as previously infected or coloing with an antiseptic solution was performed after all patient contact. The location of patients before ICU admission was recorded, as was the duration of any prior hospitalization. On the basis from other wards with a known high prevalence of MRSA, those with a prolonged stay in another ward before being transof operative status and clinical history, patients were classified as having a surgical admission when they had been operated ferred to the ICU, those with a history of hospitalization in on within 1 week before or after ICU admission, and the severCases of MRSA. There were 293 new cases of MRSA isolation in the MICU during the 4-year period (8% of admissions ity of their underlying disease was assessed by the classification described by McCabe and Jackson [21] and the new simplified or 10.5 new cases per 1,000 patient-days), of which 150 (51%) were imported and 143 (49%) were ICU-acquired (table 1) . acute physiology score (SAPS II) described by Le Gall et al. [22] first through cultures of screening samples, 45 had other sites † A global severity score [22] .
(perineum, rectum, or axilla) in addition to the anterior nares ‡ Patients were classified as having a surgical admission when they were operated on within 1 week before or after ICU admission and as having a sampled during the first positive screening in the first 2 years medical admission otherwise.
of the study (table 3) . Overall, nasal swab specimens from 38 § Includes ICU admissions from out-of-hospital emergency care facilities (84%) of 45 carriers at the time of admission were positive for and the hospital's emergency department and postemergency short-term stay (õ24 hour) ward.
MRSA, and only seven (16%) of the 45 carriers were first identified by positive screening at other sites in the absence of Overall, screening samples were obtained on one or several occasions from 1,634 patients, including 1,390 patients (38% associated nasal carriage.
Of 61 patients with imported cases detected via cultures of of all patients) during admission and later during the ICU stay and 244 other patients with prolonged ( §1 week) ICU stays. clinical diagnostic samples who were also screened for MRSA carriage at various sites, only 33 (54%) had a first screening Of these patients, 226 (14% of all patients screened or 77% of all cases) had one or more screening swab specimens positive sample that was positive; 29 of these patients had several sites sampled. MRSA was recovered from nasal swab specimens for MRSA at any time during the ICU stay; 133 patients (3.6% of all patients and 45% of all cases) had MRSA detected only from 25 (86%) of these 29 patients, including seven for whom only nasal swab specimens were positive and 14 for whom by cultures of screening swab specimens or before any clinical diagnostic sample was positive (i.e., MRSA carriers), and 93 nasal and other specimens (axilla, rectal, or perineal swab specimens) were positive for MRSA; only four patients (14%) had had positive screening samples only after clinical diagnostic samples were positive. negative nasal swab specimens together with other specimens positive for MRSA.
Clinical consequences of MRSA carriage. Infection and colonization with MRSA occurred in 142 (48.5%) and 53 Overall, 74 patients had other sites in addition to the anterior nasal mucosa swabbed for detection of MRSA carriage at the (18%) of all patients with cases of MRSA isolation, respectively, while 98 patients (33.5%) remained only carriers. Of time of ICU admission and were evaluable in this regard; nasal swab specimens were positive for 63 patients (85%), and only the 76 imported cases and the 57 ICU-acquired cases identified first by cultures of screening samples, 74% (98 of 133) respecimens from extranasal sites were first positive for 11 patients (15%) (table 3). However, four of the latter patients mained only carriers; subsequent infection and colonization occurred in 17 (22%) and 7 (9%) of imported cases who were had known prior MRSA colonization or infection; therefore, detection of MRSA carriage via cultures of nasal swab specicarriers and in 9 (16%) and 2 (3.5%) of ICU-acquired cases who were carriers (table 4) . Overall, secondary infection or mens combined with clinical information allowed the identification of ú90% (67 of 74) of all cases at the time of ICU colonization occurred at a similar rate among imported cases who were carriers and ICU-acquired cases who were carriers admission.
Screening during ICU stay. Of 3,536 patients free of (24 [32%] of 76 vs. 11 [19%] of 57, respectively; P Å .17). When present, infection or colonization occurred within a mean MRSA at the time of admission, 143 (4%) acquired MRSA carriage and/or clinical colonization or infection after a mean { SD of 6.7 { 7.3 days (median, 4 days) after the first positive screening sample for imported cases who were carriers and a ICU stay { SD of 16 { 13 days (median, 13 days). Of these 143 patients, 57 (40%) were identified first by cultures of screening mean { SD of 4.9 { 3.2 days (median, 3 days) after the first positive clinical diagnostic sample for ICU-acquired cases who samples after a median ICU stay of 14.5 days, and 86 (60%) were identified first by cultures of clinical diagnostic samples were carriers.
Mortality in cases.
The overall mortality rate in the ICU a mean { SD of 15 { 13 days (median, 12 days) after ICU admission (table 4) .
was 18%. The mean SAPS II { SD for patients with MRSA all patients admitted to the MICU were harboring MRSA at ‡ Includes two patients for whom both rectal and axilla skin swab specimens were positive for MRSA. the time of admission; more than one-half (55%) of these cases were detected by screening sample cultures, whereas only 45% of the cases were identified via cultures of clinical diagnostic samples from sites suspected of infection or colonization (table carriage, colonization, or infection was similar at the time of ICU admission (30.6 { 18, 30.1 { 17, and 33 { 17, respec-4). A relatively small proportion (30%) of carriers thus identified were previously known to be carriers or to be infected or tively); these scores were slightly higher than that for patients without cases of MRSA isolation (28.4 { 18). The mortality colonized before ICU admission, and about one-third of all MRSA carriers had subsequent infection or colonization within rates among the patients with MRSA carriage, colonization, and infection were 33.7%, 45.3%, and 57.8%, respectively a median of 4 days. Therefore, in the absence of a screening program, at least one-third of all carriers would have remained (P Å .001), and these rates were significantly higher than expected from the SAPS II for all three types of patients. occult carriers altogether, and an additional one-third would have been ignored for several days, thus likely increasing the However, the standardized mortality ratio (i.e., observed vs. expected mortality) did not differ among colonized and infected risk for cross-transmission [14] . Likewise, about one-third of ICU-acquired cases would have been undetected in the absence patients (2.45 vs. 2.61, respectively) but was lower among patients who remained only carriers (1.75; P õ .01).
of screening. Whereas adding a flag to the charts of patients and including Trends in rates of MRSA isolation and impact of the control program. The MRSA control program included four major a warning for MRSA in the computerized database of the hospital can be useful means to help readily identify previous carriers measures in addition to screening of carriers: isolation precautions, reinforced hand washing with antiseptics, skin decontamduring readmissions and implement isolation precautions pending results of repeated screening cultures [25, 26] , not all such ination of all patients from whom MRSA was isolated with chlorhexidine, and treatment of 43 carriers with nasal mupicases can be thus identified. Actually, only a small proportion of all our patients from whom MRSA was recovered were rocin. Following implementation of this program, the incidence rate of all new ICU-acquired cases and of ICU-acquired colonipreviously known to be infected or colonized.
Other investigators have shown that routine surveillance culzation or infection decreased from 5.8% and 5.6% to 2.6% and 1.4%, respectively (P Å .002 and P õ .001), while that of tures of wound and respiratory tract specimens, in addition to clinical samples for diagnostic purposes, were able to identify imported cases remained unchanged (mean, 4.1%; range, 3.8% most cases of MRSA during epidemics [11, 12] . In our study, selective screening strategy, more than one-third of patients admitted to the MICU were screened at the time of admission, although samples from most patients admitted to the MICU had been obtained from various sites at the time of admission of whom only 7.5% were found to be MRSA carriers (table  2) . Our results indicate that patients admitted from other hospiand were submitted to the microbiology laboratory for diagnostic purposes, only about one-half of the imported cases were tals and those with in-hospital stays of §4 days before transfer to the ICU are at higher risk of MRSA carriage or colonization. identified through cultures of such clinical diagnostic samples during admission. Routine surveillance cultures of specimens Restricting screening to these higher-risk groups and to those patients with prior MRSA colonization or infection would refrom clinical sites (wounds and respiratory tract) appear more likely to detect new ICU-acquired cases, especially during episult in identifying 92% of carriers detected in our study, while reducing the number of patients screened at the time of admisdemics. However, detection via cultures of clinical diagnostic samples can be delayed by several days. In our experience, a sion by 20%. To further refine the screening strategy and improve its efficiency, it would however appear desirable to better substantial proportion of ICU-acquired cases were detected via cultures of screening samples (40%), although this proportion define for each of these groups (especially patients admitted from the community) factors associated with MRSA colonizawas less than that of imported cases (50%); these figures are conservative, since not all patients were screened in our study tion, infection, or carriage on the basis of their history and clinical characteristics. and successive samples were obtained at rather long intervals. Our results are similar to those of Coello et al.
[27] who deWhen screening is performed, which sites should be sampled? We examined the yield of MRSA screening at various scribed a large hospital-wide MRSA outbreak, during which 43% of 930 patients from whom MRSA was isolated were sites after 2 years of the program. Similar to the results obtained by Coello et al.
[27], we found that ú80% of MRSA carriers identified through screening for carriage.
Because of cost and personnel considerations, we elected were identified by nasal swab cultures, while about 15% had carriage at other sites. Analyzing the yield of screening at initially to screen only patients empirically expected to be at high risk of carriage. We thus restricted screening to patients five sites, these investigators found that nasal swab cultures identified 78.5% of carriers and that the combination of nasal, with a history of hospital admission to high-risk areas (i.e., ICUs, high-risk surgery units, or long-term-stay units), repeated throat, and perineal swab cultures identified up to 98% of carriers. Other researchers have recently pointed out that the throat hospital admissions, and major surgery and to patients readmitted or transferred from other wards of the hospital. Despite this is an important reservoir for MRSA [28] ; in the study by Coello tion in a substantial proportion of patients. Pujol et al. [20] recently found that nasal carriage of MRSA in ICU patients was associated with an incidence rate of MRSA bacteremia of 38%, a rate fourfold higher than that among carriers of methicillin-susceptible S. aureus. In our study, the rates of secondary infection in carriers were lower, possibly because of preventive measures, including decolonization with chlorhexidine and the treatment of some with nasal mupirocin. Despite this apparently limited clinical impact of MRSA in carriers (which may actually reflect the efficacy of preventive measures), the importance of detecting such patients may be greater from an epidemiological standpoint for prevention of cross-transmission [14] , since early identification of carriers allows for timely implementation of control measures [24, 31] . Since several control measures were taken simultaneously would compromise the efficacy of control programs. Jernigan et al. [14] recently estimated that the risk of cross-transmission from a colonized patient who was not isolated was 0.14 per day, whereas it was of 0.009 per day when the patient was et al. [27] , throat and perineal cultures alone were positive only in 5% and 10% of cases, respectively. Sanford et al.
[29] also isolated. Further studies comparing infected or colonized patients with carriers are however needed to estimate the relative analyzed the yield of screening at various sites in high-risk patients transferred from chronic-care facilities or readmitted; risk of cross-transmission to other patients. Our study confirms recent observations that, in the current they found that nasal swab cultures had a 93% sensitivity for detection of MRSA carriage. These investigators emphasized epidemiological setting of many hospitals having endemic MRSA on the one hand and the growing pressure for early the long-term persistence (median, 3 years) of MRSA carriage in previously colonized patients.
hospital discharge with the accompanying increasing circulation of colonized patients across health care institutions and Similar to the results of Coello et al. [27] , other researchers have also found that perineal carriage may occur in 12% of within the community on the other hand, many patients colonized with MRSA can be admitted to high-risk acute-care areas. carriers in the absence of nasal carriage [30] . We however elected to restrict screening samples to nasal swab specimens In such settings, screening for early identification of carriers, which can be targeted to selected high-risk groups, appears during the second phase of the study, despite the fact that about 15% of MRSA carriers detected in the first 2 years had nonnasal warranted. carriage only. This simplification of the screening strategy did not appear to decrease the number or proportion of carriers
